Search Results - "Limonta Fernández, Miladys"
-
1
Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study
Published in Lancet Regional Health - Americas (Online) (01-12-2022)“…COVID-19 vaccines have proven safe and efficacious in reducing severe illness and death. Cuban protein subunit vaccine Abdala has shown safety, tolerability…”
Get full text
Journal Article -
2
Evaluation of methodologies to determine the effect of specific active immunotherapy on VEGF levels in phase I clinical trial patients with advanced solid tumors
Published in Heliyon (01-11-2018)“…Two phase I clinical trials were conducted to evaluate, among other parameters, the humoral response elicited by a vascular endothelial growth factor…”
Get full text
Journal Article -
3
An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
Published in New biotechnology (25-12-2022)“…Developing affordable and easily manufactured SARS-CoV-2 vaccines will be essential to achieve worldwide vaccine coverage and long-term control of the COVID-19…”
Get full text
Journal Article -
4
Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1-2 Clinical Trial
Published in Vaccines (Basel) (01-09-2024)“…A phase 1-2, prospective, multicenter, randomized, open-label clinical trial (Code RPCEC00000382), with parallel groups, involving 1161 participants, was…”
Get full text
Journal Article -
5
Correction to “Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study” [The Lancet Regional Health – Americas 2022; 16: 100366] https://doi.org/10.1016/j.lana.2022.100366
Published in Lancet Regional Health - Americas (Online) (01-02-2023)“…[This corrects the article DOI: 10.1016/j.lana.2022.100366.]…”
Get full text
Journal Article -
6
Nuevas contribuciones al estudio de los efectores inmunológicos inducidos con la inmunoterapia activa específica CIGB-247
Published in Anales de la Academia de Ciencias de Cuba (01-02-2022)“…Objetivos. Esta investigación tiene como objetivo estudiar los efectores inmunológicos que se inducen en los pacientes inmunizados con el CIGB-247, que…”
Get full text
Journal Article -
7
Efficacy and safety of Abdala COVID-19 subunit vaccine in children and adolescents: An open-label, single-arm, phase 2 trial (MEÑIQUE)
Published in Vaccine (17-09-2024)“…Objectives We evaluated the safety, immunogenicity and efficacy of Abdala, a protein subunit vaccine for 2019 coronavirus disease (COVID-19), in children and…”
Get full text
Journal Article -
8
Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)
Published in EClinicalMedicine (01-04-2022)“…Multiple vaccine candidates against COVID-19 are currently being evaluated. We evaluate the safety and immunogenicity protein of a novel SARS-CoV-2 virus…”
Get full text
Journal Article -
9
A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study)
Published in Lancet Regional Health - Americas (Online) (01-05-2023)“…The pandemic of COVID-19 raised the urgent need for safe and efficacious vaccines against SARS-CoV-2. We evaluated the efficacy and safety of a new SARS-CoV-2…”
Get full text
Journal Article -
10
Epidermal Growth Factor Intralesional Delivery in Chronic Wounds: The Pioneer and Standalone Technique for Reversing Wound Chronicity and Promoting Sustainable Healing
Published in International journal of molecular sciences (10-10-2024)“…The early expectations about growth factors' (GFs') discovery as an undisputed therapeutic solution for chronic wounds progressively eclipsed when they failed…”
Get full text
Journal Article -
11
Effect of the Selection Marker on the Viability and Plasmid Stability of Two Human Proteins with Neurotrophic Action Expressed inEscherichia coli
Published in Biochemical and biophysical research communications (29-04-1999)“…Most developed expression systems rely on the production of fusion proteins or the change of selection marker increasing genetic stability to avoid toxicity of…”
Get full text
Journal Article -
12
Effect of the selection marker on the viability and plasmid stability of two human proteins with neurotrophic action expressed in Escherichia coli
Published in Biochemical and biophysical research communications (29-04-1999)“…Most developed expression systems rely on the production of fusion proteins or the change of selection marker increasing genetic stability to avoid toxicity of…”
Get full text
Journal Article -
13
Scale up of fed-batch culture to produce plasmid DNA in Escherichia coli
Published in Biopharm International (01-07-2012)“…Scale-up from a 5-L fermentor to a 50-L pilot-scale fermentor was carried out successfully using the criterion of constant power consumption per unit liquid…”
Get full text
Magazine Article Trade Publication Article -
14
High-cell-density culture to produce plasmid DNA for gene therapy in E. coli
Published in Biopharm International (01-07-2009)“…The recombinant host Escherichia coli DH10B bearing the plasmid pIDKE2 was grown under fed batch conditions, and the effects of different medium components on…”
Get full text
Magazine Article Trade Publication Article -
15
Design of the purification process by metal-chelate affinity chromatography of a new vaccine antigen for the control of sea lice
Published in Biotecnología Aplicada“…The present work aims at designing the purification process of protein MY32/Ls to obtain the active pharmaceutical ingredient (API) against sea lice, marine…”
Get full text
Journal Article